These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8853547)

  • 1. Quantitative and in vivo activity of adenoviral-producing cells made by cotransduction of a replication-defective adenovirus and a replication-enabling plasmid.
    Dion LD; Goldsmith KT; Garver RI
    Cancer Gene Ther; 1996; 3(4):230-7. PubMed ID: 8853547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with conditionally replicating adenovirus and replication defective adenovirus.
    Lee CT; Park KH; Yanagisawa K; Adachi Y; Ohm JE; Nadaf S; Dikov MM; Curiel DT; Carbone DP
    Cancer Res; 2004 Sep; 64(18):6660-5. PubMed ID: 15374981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo imaging of adenovirus transduction and enhanced therapeutic efficacy of combination therapy with conditionally replicating adenovirus and adenovirus-p27.
    Lee CT; Lee YJ; Kwon SY; Lee J; Kim KI; Park KH; Kang JH; Yoo CG; Kim YW; Han SK; Chung JK; Shim YS; Curiel DT; Carbone DP
    Cancer Res; 2006 Jan; 66(1):372-7. PubMed ID: 16397251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E1A RNA transcripts amplify adenovirus-mediated tumor reduction.
    Dion LD; Goldsmith KT; Strong TV; Bilbao G; Curiel DT; Garver RI
    Gene Ther; 1996 Nov; 3(11):1021-5. PubMed ID: 9044743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. trans E1 component requirements for maximal replication of E1-defective recombinant adenovirus.
    Goldsmith KT; Dion LD; Curiel DT; Garver RI
    Virology; 1998 Sep; 248(2):406-19. PubMed ID: 9721248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trans complementation of an E1A-deleted adenovirus with codelivered E1A sequences to make recombinant adenoviral producer cells.
    Goldsmith KT; Curiel DT; Engler JA; Garver RI
    Hum Gene Ther; 1994 Nov; 5(11):1341-8. PubMed ID: 7893805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus replication-competent vectors (KD1, KD3) complement the cytotoxicity and transgene expression from replication-defective vectors (Ad-GFP, Ad-Luc).
    Habib NA; Mitry R; Seth P; Kuppuswamy M; Doronin K; Toth K; Krajcsi P; Tollefson AE; Wold WS
    Cancer Gene Ther; 2002 Aug; 9(8):651-4. PubMed ID: 12136425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.
    Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M
    Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse.
    Paielli DL; Wing MS; Rogulski KR; Gilbert JD; Kolozsvary A; Kim JH; Hughes J; Schnell M; Thompson T; Freytag SO
    Mol Ther; 2000 Mar; 1(3):263-74. PubMed ID: 10933942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linked tumor-selective virus replication and transgene expression from E3-containing oncolytic adenoviruses.
    Zhu M; Bristol JA; Xie Y; Mina M; Ji H; Forry-Schaudies S; Ennist DL
    J Virol; 2005 May; 79(9):5455-65. PubMed ID: 15827160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase.
    Dion LD; Goldsmith KT; Tang DC; Engler JA; Yoshida M; Garver RI
    Virology; 1997 May; 231(2):201-9. PubMed ID: 9168882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
    Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementation of a defective human adenovirus by an otherwise incompatible ovine adenovirus recombinant carrying a functional E1A gene.
    Lockett LJ; Both GW
    Virology; 2002 Mar; 294(2):333-41. PubMed ID: 12009875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled transgene expression by E1-E4-defective adenovirus vectors harbouring a "tet-on" switch system.
    Fender P; Jeanson L; Ivanov MA; Colin P; Mallet J; Dedieu JF; Latta-Mahieu M
    J Gene Med; 2002; 4(6):668-75. PubMed ID: 12439858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
    Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO
    J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycations and cationic lipids enhance adenovirus transduction and transgene expression in tumor cells.
    Clark PR; Stopeck AT; Brailey JL; Wang Q; McArthur J; Finer MH; Hersh EM
    Cancer Gene Ther; 1999; 6(5):437-46. PubMed ID: 10505854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer.
    Maemondo M; Saijo Y; Narumi K; Kikuchi T; Usui K; Tazawa R; Matsumoto K; Nakamura T; Sasaki K; Takahashi M; Niitsu Y; Nukiwa T
    Cancer Res; 2004 Jul; 64(13):4611-20. PubMed ID: 15231673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.